CALC CalciMedica, Inc.
Company Analysis
Latest News
🟢 CalciMedica is trading 5.9% up today as it rebounds from recent volatility without a clear catalyst
CalciMedica is trading at $0.78 (+5.9%) in after-hours sessions, rebounding from a sharp drop on Thursday despite a lack of company-specific news. * The move...
🟢 CalciMedica is trading 10.0% up
CalciMedica is trading at $0.76, up 10.0% from a comparison close of $0.69 during regular trading. This is a price-action follow-up, so a separate catalyst may...
🟢 CalciMedica is trading 5.2% up today in a technical rebound after recent declines
CalciMedica is trading at $0.73 (5.2%) up today, continuing a rebound following a string of sharp declines over the past week. • The move appears to be...
🟢 CalciMedica is trading 5.9% up today extending an idiosyncratic rebound
CalciMedica is trading at $0.73 (5.9%) up today, extending an idiosyncratic rebound after recent sharp declines. • There are no fresh earnings, FDA updates,...
🟢 CalciMedica is trading 6.6% up today
CalciMedica is trading at $0.74 (+6.59%) in after-hours trading, showing an idiosyncratic rebound despite a lack of company-specific news. • No earnings...
🔴 CalciMedica is trading 11.8% down
CalciMedica is trading at $0.69, down 11.8% from a comparison close of $0.78 during regular trading. This is a price-action follow-up, so a separate catalyst...
🔴 CalciMedica, Inc. is trading 5.36% down in pre-market
CALC is trading at $0.74, down 5.36% in pre-market.
🟢 CalciMedica, Inc. is trading 6.57% up in pre-market
CALC is trading at $0.87, up 6.57% in pre-market.
🟢 CalciMedica is trading 5.1% up today on after-hours rebound, following Alafi Capital's recent 17.1% stake disclosure
CalciMedica is trading at $0.86 (5.1% up) in after-hours, staging a recovery after a sharp drop during the regular trading session. • The stock is rebounding...
🟢 CalciMedica is trading 5.1% up today on a speculative after-hours rebound
CalciMedica is trading at $0.86 (5.1%) up in after-hours trading as shares stage a speculative rebound following a volatile regular session. • The stock...
🟢 CalciMedica is trading 13.2% up today on speculative after-hours activity
CalciMedica is trading at $0.93 (+13.19%) in after-hours trading following a sharp rebound from its regular session close of $0.82, despite no clear...
🔴 CalciMedica is trading 10.4% down
CalciMedica is trading at $0.83, down 10.4% from a comparison close of $0.93 during regular trading. This is a price-action follow-up, so a separate catalyst...
🔴 CalciMedica is trading 5.99% down today on Nasdaq delisting risk and biotech sector weakness
CalciMedica is trading at $0.87 (5.99% down) as investors react to ongoing Nasdaq delisting risk and a weak biotech tape. • The company recently disclosed...
🔴 CalciMedica is trading 6.3% down today after board-appointment rally and profit-taking
CalciMedica is trading at $0.89 (6.3% down) as the stock faces profit-taking pressure following a short-lived rally driven by a board expansion. • The stock...
🔴 CalciMedica is trading 5.3% down today as after-hours profit-taking follows board expansion rally
CalciMedica is trading at $0.90 (5.3% down) in after-hours sessions as investors lock in gains following a board-related rally during regular trading. • The...
🟢 CalciMedica is trading 5.6% up today after announcing board expansion and new director appointment
CalciMedica is trading 5.6% up at $0.95 after announcing changes to its board of directors. • The company expanded its board from seven to eight members and...
🟢 CalciMedica is trading 6.2% up today after announcing board changes
• CalciMedica is trading at $0.96 (up 6.2%) in pre-market action following news of a shift in top management. • The company announced on July 8, 2026, an...
🔴 CALC extends move to 5.8% down
CALC is trading at $0.90, down 5.8% versus the comparison close of $0.96 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 CALC is trading 5.7% down today as trial discontinuation fallout continues
CALC is trading 5.7% down at $0.90 in pre-market, extending recent weakness following a major clinical trial setback. • The company recently announced it...
CalciMedica Appoints Dr. Evgeny Zaytsev to Board, Announces Director Retirement
CalciMedica announced changes to its Board of Directors, appointing Evgeny Zaytsev, M.D., Ph.D., as a new director and announcing the upcoming retirement of...